Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a80cbaaeee718664126e579cf4e41c2 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
filingDate |
2007-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0dbcc7f4b4d5333f54cf6c92b6eee7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1b1afe59f653240a124bbfcf6264220 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0843fcbd22665ace432430efe12f5efe |
publicationDate |
2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2666293-C |
titleOfInvention |
Use of the melatonin agonist (1r-trans)-n[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide in the treatment of circadian and sleep disorders |
abstract |
This invention provides the use of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl) cyclopropyl]methyl]propanamide as a melatonin receptor agonist to a human subject to treat or prevent a circadian rhythm disorder or sleep disorder. More specifically, it discloses the use of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide (MA-1) for the preparation of a pharmaceutical composition for the treatment of a circadian rhythm disorder or a sleep disorder, the pharmaceutical composition being formulated for orally administering MA-1 to the subject suffering such disorder in an amount of about 20 mg to about 50 mg per day. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10149829-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10449176-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9855241-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10945988-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11285129-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11633377-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10610510-B2 |
priorityDate |
2006-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |